Summary : Pfizer Chief Executive Officer Albert Bourla called 2021 a watershed year for the company. It posted $81.3 billion in revenue…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Companies
-
-
Summary : The U.S. Food and Drug Administration approved Sanofi’s proposed drug to address red blood cell destruction in patients living with…
-
CompaniesPfizerRegulatoryU.S FDA
FDA Pushes Pfizer COVID Vaccine for 6 Month to 5 Years Kids
by adminby adminSummary : A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old…
-
RegulatorySanofiU.S FDA
FDA approves Enjaymo™ (sutimlimab-jome), First Treatment for use in Patients with Cold Agglutinin Disease
by adminby adminSummary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…
-
Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for…
-
CompaniesGlobal MarketNovartis
Financials Indicate Novartis’ Sandoz Division Could Be a Tough Sell
by adminby adminSynopsis : Novartis reported its full-year financials this week for 2021, and overall, the news was good. Full-year net sales grew 4%,…
-
AgrochemicalsBiogenGlobal Market
Biogen’s Aduhelm Grabs the Spotlight at User Fee Renewals Hearing
by adminby adminSummary – The House Energy and Commerce Committee’s health panel met to discuss renewing user fee agreements used to fund the U.S.…
-
CompaniesPfizer
Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate
by adminby adminSynopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive…
-
CompaniesPfizer
Pfizer Alleges Stolen Trade Secrets at Heart of Regor Therapeutics Launch
by adminby adminSynopsis : A $1.5 billion diabetes partnership between Eli Lilly and China-based Regor Therapeutics Group is at the center of a lawsuit…
-
GileadGlobal MarketPatentsRegulatory
Gilead’s Strong Financials Marred by $1.25B ViiV Patent Settlement
by adminby adminSummary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute…